Qatari German Company for Medical Devices (Q.P.S.C.) carries a market capitalization of 151.42M, placing it among publicly traded companies globally. Its enterprise value stands at 294.49M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 151.42M |
| Enterprise Value | 294.49M |
Qatari German Company for Medical Devices (Q.P.S.C.) currently has 115.50M shares outstanding.
| Shares Outstanding | 115.50M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Qatari German Company for Medical Devices (Q.P.S.C.) trades at a trailing price-to-earnings ratio of 14.85. The price-to-sales ratio is 32.11, and the price-to-book ratio stands at -2.26.
| PE Ratio | 14.85 |
| PS Ratio | 32.11 |
| PB Ratio | -2.26 |
| P/TBV Ratio | -4.76 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
| EV / Sales | 61.67 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 196.75 |
Qatari German Company for Medical Devices (Q.P.S.C.) maintains a current ratio of 0.83, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -589.56, indicating conservative leverage, while an interest coverage ratio of -4.56 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.83 |
| Quick Ratio | 0.01 |
| Debt / Equity | -589.56 |
| Debt / EBITDA | -20.71 |
| Interest Coverage | -4.56 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 7.52 |
| Return on Invested Capital (ROIC) | -5.83 |
| Return on Capital Employed (ROCE) | 16.06 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.19 |
Qatari German Company for Medical Devices (Q.P.S.C.)'s stock has declined approximately -9.58621% over the past 52 weeks. The 50-day moving average sits at 1.43, while the 200-day moving average is 1.49.
| Beta (5Y) | N/A |
| 52-Week Price Change | -9.58621% |
| 50-Day Moving Average | 1.43 |
| 200-Day Moving Average | 1.49 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Qatari German Company for Medical Devices (Q.P.S.C.) generated 4.78M in revenue and converted that into 10.33M in net income, yielding earnings per share of 0.09. EBITDA reached -6.82M, while operating income came in at -6.82M.
| Revenue | 4.78M |
| Gross Profit | 1.89M |
| Operating Income | -6.82M |
| Pretax Income | 10.33M |
| Net Income | 10.33M |
| EBITDA | -6.82M |
| EBIT | -6.82M |
| Earnings Per Share (EPS) | 0.09 |
Qatari German Company for Medical Devices (Q.P.S.C.) holds 169,678.00 in cash and equivalents against 141.33M in total debt, resulting in a net debt position of 141.10M. Total book value stands at -67.86M, with working capital of -3.72M providing operational flexibility.
| Cash & Cash Equivalents | 169,678.00 |
| Total Debt | 141.33M |
| Net Debt | 141.10M |
| Equity (Book Value) | -67.86M |
| Book Value Per Share | -0.59 |
| Working Capital | -3.72M |
Qatari German Company for Medical Devices (Q.P.S.C.) operates with a gross margin of 39.51, reflecting its pricing power and cost economics. The operating margin of -142.89 and net profit margin of 216.27 provide insight into operational efficiency.
| Gross Margin | 39.51 |
| Operating Margin | -142.89 |
| Pretax Margin | 216.27 |
| Profit Margin | 216.27 |
| EBITDA Margin | -142.89 |
Qatari German Company for Medical Devices (Q.P.S.C.)'s most recent stock split took place on June 19, 2019 with a 1:10 split ratio.
| Last Split Date | 6/19/2019 |
| Split Ratio | 1:10 |
Qatari German Company for Medical Devices (Q.P.S.C.) posts an Altman Z-Score of -1.64, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1.64 |